Upgrade to SI Premium - Free Trial

Kenvue (KVUE)

19.04 -0.24 (1.24%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Kenvue to Announce Third Quarter 2026 Results on October 30, 2026 October 21, 2026 5:00 PM - BizWire Kimberly-Clark wins EU approval for Kenvue acquisition October 13, 2026 10:13 AM - StreetInsider Form 8-K Kenvue Inc. For: Oct 09 October 13, 2026 7:27 AM - SEC Filing Kimberly-Clark secures consents to amend Kenvue notes in exchange offer October 13, 2026 7:01 AM - StreetInsider Kimberly-Clark Announces Successful Consent Solicitations for Kenvue Notes and Amendment to Terms of Exchange Offers October 13, 2026 7:00 AM - PR NewsWire Form 4 Kenvue Inc. For: Oct 02 Filed by: Lawson Carlton October 6, 2026 9:06 PM - SEC Filing Form 4 Kenvue Inc. For: Oct 02 Filed by: Stevens Meredith October 6, 2026 9:06 PM - SEC Filing Form 4 Kenvue Inc. For: Oct 02 Filed by: Orlando Matthew October 6, 2026 9:06 PM - SEC Filing Form 4 Kenvue Inc. For: Oct 02 Filed by: Howlett Heather October 6, 2026 9:06 PM - SEC Filing Form 4 Kenvue Inc. For: Oct 02 Filed by: Tillett Caroline October 6, 2026 9:06 PM - SEC Filing Form 4 Kenvue Inc. For: Oct 01 Filed by: Wondrasch Michael October 5, 2026 6:11 PM - SEC Filing Kimberly-Clark announces leadership changes ahead of Kenvue deal close October 1, 2026 7:03 AM - StreetInsider Kimberly-Clark Announces Planned Executive Transitions and Updates to Post-Closing Leadership Team October 1, 2026 7:00 AM - PR NewsWire LISTERINE® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 Billion October 1, 2026 6:45 AM - BizWire Kenvue brands present skin and hair research at EADV congress September 30, 2026 6:46 AM - StreetInsider Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair September 30, 2026 6:45 AM - BizWire Form 4 Kenvue Inc. For: Sep 28 Filed by: Smith Jeffrey C September 29, 2026 6:48 PM - SEC Filing Form 4 Kenvue Inc. For: Sep 25 Filed by: Stevens Meredith September 29, 2026 4:32 PM - SEC Filing Form 4 Kenvue Inc. For: Sep 28 Filed by: ALLISON RICHARD E JR September 29, 2026 4:32 PM - SEC Filing Kimberly-Clark Corporation Announces Commencement of Exchange Offers and Consent Solicitations for Kenvue Notes September 28, 2026 4:05 PM - PR NewsWire Kimberly-Clark Preparing Asset Sales In Bid For EU Approval Of $40 Billion Kenvue Deal - Reuters September 14, 2026 6:53 AM - StreetInsider Kenvue (KVUE) Declares $0.21 Quarterly Dividend; 4.7% Yield September 10, 2026 6:45 AM - StreetInsider Kenvue Declares Quarterly Cash Dividend September 10, 2026 6:45 AM - BizWire Essity to buy Kenvue's feminine care brands in Brazil for $284m August 19, 2026 1:07 PM - StreetInsider Goldman Sachs reviews US consumer staples sales data for August from NielsenIQ August 18, 2026 8:48 AM - StreetInsider Kimberly-Clark names Suzana Blades as SVP and general counsel August 13, 2026 9:25 AM - StreetInsider Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel August 13, 2026 9:25 AM - PR NewsWire Form SCHEDULE 13G/A Kenvue Inc. Filed by: FMR LLC August 6, 2026 10:31 AM - SEC Filing Form 10-Q Kenvue Inc. For: Jun 28 August 6, 2026 7:01 AM - SEC Filing Kenvue Inc. (KVUE) Misses Q2 EPS by 1c August 6, 2026 6:57 AM - StreetInsider Kenvue Inc. (KVUE) Misses Q2 EPS by 1c August 6, 2026 6:51 AM - StreetInsider Form 8-K Kenvue Inc. For: Aug 06 August 6, 2026 6:48 AM - SEC Filing Kenvue Reports Second Quarter 2026 Results August 6, 2026 6:45 AM - BizWire Kenvue (KVUE) call put ratio 1 call to 1.7 puts into quarter results August 5, 2026 11:08 AM - StreetInsider Form 4 Kenvue Inc. For: Jul 31 Filed by: Dasgupta Anindya August 4, 2026 4:32 PM - SEC Filing Kenvue (KVUE) Declares $0.21 Quarterly Dividend; 4.3% Yield July 29, 2026 6:45 AM - StreetInsider Kenvue Increases Quarterly Cash Dividend July 29, 2026 6:45 AM - BizWire Kenvue (KVUE) 4400 contracts of July 31 weekly 19.50 calls trade July 27, 2026 2:46 PM - StreetInsider FDA approves Tylenol with Naproxen as first OTC combo pain reliever July 24, 2026 2:02 PM - StreetInsider Kenvue to Announce Second Quarter 2026 Results on August 6, 2026 July 23, 2026 6:45 AM - BizWire Full Article List